ID

13648

Beschreibung

Documentation part: Table II [Recommendations for core asthma outcomes for NIH- initiated clinical research for adults and adolescents (>= 12 years of age)]. ODM derived from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259286/ Background: Asthma clinical research will highly benefit from standardization of major outcomes in terms of definition and assessment methodology. This will permit useful comparisons across interventional or observational studies and will allow more effective data sharing. Objective: National Institutes of Health (NIH) institutes and the Agency for Healthcare Research and Quality (AHRQ) convened a workshop involving 7 expert subcommittees to propose which asthma outcomes should be assessed with standardized methodology in future asthma clinical research studies. Permission granted by: Michelle Freemer.

Link

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259286/

Stichworte

  1. 5/1/16 5/1/16 -
  2. 23/2/16 23/2/16 -
Hochgeladen am

23 de febrero de 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

Characterization of study population for prospective clinical trials
Beschreibung

Characterization of study population for prospective clinical trials

Alias
UMLS CUI-1
C2348561
UMLS CUI-2
C1880022
UMLS CUI-4
C0008976
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
Beschreibung

Biomarkers Serologic

Datentyp

text

Alias
UMLS CUI [1,1]
C0005516
UMLS CUI [1,2]
C0205473
Composite scores: Either ACQ or ACT
Beschreibung

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Datentyp

text

Alias
UMLS CUI [1]
C2919686
Events in the 12 months prior to study entry:
Beschreibung

Exacerbation of asthma

Datentyp

text

Alias
UMLS CUI [1]
C0349790
History of:
Beschreibung

Utilization healthcare; Costs healthcare

Datentyp

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
Pulmonary physiology: Spirometry (pre­ and post­ bronchodilator)
Beschreibung

Spirometry

Datentyp

text

Alias
UMLS CUI [1]
C0037981
Prospective clinical trial efficacy/ effectiveness outcomes
Beschreibung

Prospective clinical trial efficacy/ effectiveness outcomes

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C1280519
Composite Scores: Either ACQ or ACT
Beschreibung

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Datentyp

text

Alias
UMLS CUI [1]
C2919686
Events in the 12 months prior to study entry:
Beschreibung

Exacerbation of asthma

Datentyp

text

Alias
UMLS CUI [1]
C0349790
History of:
Beschreibung

Utilization healthcare; Costs healthcare

Datentyp

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Beschreibung

medication asthma

Datentyp

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Physiology Pulmonary: Spirometry (without bronchodilator)
Beschreibung

Spirometry

Datentyp

text

Alias
UMLS CUI [1]
C0037981
Observational study outcomes
Beschreibung

Observational study outcomes

Alias
UMLS CUI-1
C1518527
UMLS CUI-2
C0086749
Composite Scores: Either ACQ or ACT
Beschreibung

ACQ (Asthma Control Questionnaire) ACT (Asthma Control Test)

Datentyp

text

Alias
UMLS CUI [1]
C2919686
Events in the 12 months prior to study entry:
Beschreibung

Exacerbation of asthma

Datentyp

text

Alias
UMLS CUI [1]
C0349790
History of:
Beschreibung

Utilization healthcare; Costs healthcare

Datentyp

text

Alias
UMLS CUI [1,1]
C0042153
UMLS CUI [1,2]
C0086388
UMLS CUI [2,1]
C0010186
UMLS CUI [2,2]
C0086388
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
Beschreibung

medication asthma

Datentyp

text

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
Physiology Pulmonary: Spirometry (pre­ and post­ bronchodilator)
Beschreibung

Spirometry

Datentyp

text

Alias
UMLS CUI [1]
C0037981

Ähnliche Modelle

Table II- Core Asthma Outcomes NIH AHRQ for adults and adolescents >= 12 years of age

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Characterization of study population for prospective clinical trials
C2348561 (UMLS CUI-1)
C1880022 (UMLS CUI-2)
C0008976 (UMLS CUI-4)
Biomarkers Serologic
Item
Serologic multi­allergen screen (IgE) to define atopic status (also for observational studies)
text
C0005516 (UMLS CUI [1,1])
C0205473 (UMLS CUI [1,2])
Item
Composite scores: Either ACQ or ACT
text
C2919686 (UMLS CUI [1])
Code List
Composite scores: Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
CL Item
Asthma-­specific hospital admissions (1)
CL Item
Asthma­-specific ED visits (2)
CL Item
Asthma-­specific outpatient visits (3)
CL Item
Asthma-­specific medication use (4)
Spirometry
Item
Pulmonary physiology: Spirometry (pre­ and post­ bronchodilator)
text
C0037981 (UMLS CUI [1])
Item Group
Prospective clinical trial efficacy/ effectiveness outcomes
C0008976 (UMLS CUI-1)
C1280519 (UMLS CUI-2)
Item
Composite Scores: Either ACQ or ACT
text
C2919686 (UMLS CUI [1])
Code List
Composite Scores: Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma, for at least 3 days (1)
CL Item
Asthma-­specific hospital admissions (2)
CL Item
 Asthma-­specific ED visits (separate UC visits when these can be differentiated) (3)
CL Item
Asthma-­specific ICU admissions/intubations (4)
CL Item
 Death (all cause and asthma related) (5)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Spirometry
Item
Physiology Pulmonary: Spirometry (without bronchodilator)
text
C0037981 (UMLS CUI [1])
Item Group
Observational study outcomes
C1518527 (UMLS CUI-1)
C0086749 (UMLS CUI-2)
Item
Composite Scores: Either ACQ or ACT
text
C2919686 (UMLS CUI [1])
Code List
Composite Scores: Either ACQ or ACT
CL Item
ACQ  (1)
CL Item
ACT (2)
Item
Events in the 12 months prior to study entry:
text
C0349790 (UMLS CUI [1])
Code List
Events in the 12 months prior to study entry:
CL Item
Systemic corticosteroids for asthma (1)
CL Item
Asthma­-specific hospital admissions (2)
CL Item
Asthma­-specific ED visits (separate UC visits when these can be differentiated) (3)
Item
History of:
text
C0042153 (UMLS CUI [1,1])
C0086388 (UMLS CUI [1,2])
C0010186 (UMLS CUI [2,1])
C0086388 (UMLS CUI [2,2])
CL Item
Asthma-­specific hospital admissions  (1)
CL Item
Asthma­-specific ED visits  (2)
CL Item
Asthma-­specific outpatient visits  (3)
CL Item
Asthma-­specific detailed medication use (name, dose, duration) (4)
CL Item
Resource use related to the intervention (eg, personnel time, mite eradication, equipment) (5)
medication asthma
Item
If option 4 chosen above, please mention the name, dose and duration of the asthma medication used
text
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
Spirometry
Item
Physiology Pulmonary: Spirometry (pre­ and post­ bronchodilator)
text
C0037981 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video